Clinical Features to Predict 22q11.2 Deletion Syndrome Proven by Molecular Genetic Testing

Abstract

The 22q11.2 deletion syndrome (22q11.2 DS) is the most common microdeletion syndrome with a wide variety of clinical features. However, as there are no clinical criteria for diagnosis, confirmation is solely done by genetic tests if clinicians recognize the syndrome. Therefore, we aimed to identify clinical features that may help clinicians recognize 22q11.2 DS. Participants with at least two anomalies were enrolled, complete patient history and physical examinations were performed, then multiplex ligation-dependent probe amplification (MLPA) analysis for 22q11.2 DS was utilized. We identified 11/48 (23%) cases with 22q11.2 DS. Palatal anomalies, hypocalcemia, and ≥3 affected body systems were highly significant presentations in the 22q11.2 DS group versus the group without deletion (p < 0.05). Therefore, a comprehensive physical examination is crucial at identifying any subtle features which may lead to testing and a definite diagnosis.

Keywords

22q11.2 deletion syndrome - multiplex ligation-dependent probe amplification - clinical prediction

• References

• 1 McDonald-McGinn DM, Sullivan KE, Marino B. et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers 2015; 1: 15071
• 2 Tézenas Du Montcel S, Mendizabai H, Aymé S, Lévy A, Philip N. Prevalence of 22q11 microdeletion. J Med Genet 1996; 33 (08) 719
• 3 Oskarsdóttir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004; 89 (02) 148-151
• 4 Botto LD, May K, Fernhoff PM. et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112 (1 Pt 1): 101-107
• 5 Tan KB, Chew SK, Yeo GS. 22q11.2 deletion syndrome in Singapore (2000-2003): a case for active ascertainment. Singapore Med J 2008; 49 (04) 286-289
• 6 Maisenbacher MK, Merrion K, Pettersen B. et al. Incidence of the 22q11.2 deletion in a large cohort of miscarriage samples. Mol Cytogenet 2017; 10: 6
• 7 Li C, Chen B, Zheng J. et al. Prenatal Diagnosis of BACs-on-Beads Assay in 3647 Cases of Amniotic Fluid Cells. Reprod Sci 2019; 26 (07) 1005-1012
• 8 Robin NH, Shprintzen RJ. Defining the clinical spectrum of deletion 22q11.2. J Pediatr 2005; 147 (01) 90-96
• 9 McDonald-McGinn DM, Hain HS, Emanuel BS. et al. 22q11.2 deletion syndrome. In: Adam MP, Ardinger HH, Pagon RA. et al., eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 1993-2020
• 10 Bassett AS, McDonald-McGinn DM, Devriendt K. International 22q11.2 Deletion Syndrome Consortium. et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159 (02) 332-9.e1
• 11 Digilio M, Marino B, Capolino R, Dallapiccola B. Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome). Images Paediatr Cardiol 2005; 7 (02) 23-34
• 12 McDonald-McGinn DM, Minugh-Purvis N, Kirschner RE. et al. The 22q11.2 deletion in African-American patients: an underdiagnosed population?. Am J Med Genet A 2005; 134 (03) 242-246
• 13 Kruszka P, Addissie YA, McGinn DE. et al. 22q11.2 deletion syndrome in diverse populations. Am J Med Genet A 2017; 173 (04) 879-888
• 14 McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90 (01) 1-18
• 15 Hu Y, Zhu X, Yang Y. et al. Incidences of micro-deletion/duplication 22q11.2 detected by multiplex ligation-dependent probe amplification in patients with congenital cardiac disease who are scheduled for cardiac surgery. Cardiol Young 2009; 19 (02) 179-184
• 16 Sørensen KM, Agergaard P, Olesen C. et al. Detecting 22q11.2 deletions by use of multiplex ligation-dependent probe amplification on DNA from neonatal dried blood spot samples. J Mol Diagn 2010; 12 (02) 147-151
• 17 Stachon AC, Baskin B, Smith AC. et al. Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification. Am J Med Genet A 2007; 143A (24) 2924-2930
• 18 Kushima I, Aleksic B, Nakatochi M. et al. Comparative analyses of copy-number variation in autism spectrum disorder and schizophrenia reveal etiological overlap and biological insights. Cell Reports 2018; 24 (11) 2838-2856
• 19 Monteiro FP, Vieira TP, Sgardioli IC. et al. Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature. Eur J Pediatr 2013; 172 (07) 927-945
• 20 Vieira TP, Monteiro FP, Sgardioli IC. et al. Clinical features in patients with 22q11.2 deletion syndrome ascertained by palatal abnormalities. Cleft Palate Craniofac J 2015; 52 (04) 411-416
• 21 Sivertsen A, Lie RT, Wilcox AJ. et al. Prevalence of duplications and deletions of the 22q11 DiGeorge syndrome region in a population-based sample of infants with cleft palate. Am J Med Genet A 2007; 143A [phone]
• 22 Agergaard P, Olesen C, Østergaard JR, Christiansen M, Sørensen KM. The prevalence of chromosome 22q11.2 deletions in 2,478 children with cardiovascular malformations. A population-based study. Am J Med Genet A 2012; 158A [phone]
• 23 Iserin L, de Lonlay P, Viot G. et al. Prevalence of the microdeletion 22q11 in newborn infants with congenital conotruncal cardiac anomalies. Eur J Pediatr 1998; 157 (11) 881-884
• 24 Goldmuntz E. 22q11.2 deletion syndrome and congenital heart disease. Am J Med Genet C Semin Med Genet 2020; 184 (01) 64-72
• 25 Tobias ES, Morrison N, Whiteford ML, Tolmie JL. Towards earlier diagnosis of 22q11 deletions. Arch Dis Child 1999; 81 (06) 513-514
• 26 MRC-Holland. MS-MLPA general protocol. Accessed 12 Dec, 2018 at: https://www.mrcholland.com/products
• 27 van Engelen K, Topf A, Keavney BD. et al. 22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. Heart 2010; 96 (08) 621-624
• 28 Digilio MC, Marino B, Giannotti A, Dallapiccola B. Chromosome 22q11 microdeletion and isolated conotruncal heart defects. Arch Dis Child 1997; 76 (01) 79-80
• 29 Bassett AS, Chow EW, Husted J. et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A 2005; 138 (04) 307-313
• 30 Campbell IM, Sheppard SE, Crowley TB. et al. What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. Am J Med Genet A 2018; 176 (10) 2058-2069
• 31 Agergaard P, Hebert A, Sørensen KM, Østergaard JR, Olesen C. Can clinical assessment detect 22q11.2 deletions in patients with cardiac malformations? A review. Eur J Med Genet 2011; 54 (01) 3-8
• 32 Persson C, Friman V, Óskarsdóttir S, Jönsson R. Speech and hearing in adults with 22q11.2 deletion syndrome. Am J Med Genet A 2012; 158A (12) 3071-3079